Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Targeting colon cancer stem cells might lead to better treatment results.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Understanding different species' regeneration can improve mammalian healing.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Different types of skin cells play specific roles in development, healing, and cancer.

Paneth cells help support stem cells and aid tissue regeneration after injury.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Overactive sonic hedgehog signaling worsens uterine scarring by reducing cell recycling.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Four circRNAs were found to be significantly different in cashmere goat skin, affecting cashmere fineness.